Amesite’s AI Tool Earns Nurse Nod, Eyes $800B Healthcare Market
- $800B Market Opportunity: Amesite’s NurseMagic™ targets the U.S. post-acute care market, projected to reach $800B by 2035.
- 82% Revenue Jump: Amesite reported an 82% quarter-over-quarter revenue increase after launching its Enterprise tier in July 2025.
- 2.4x Growth: The company saw a 2.4x revenue increase following the launch of its Teams+ tier in May 2025.
Experts view Amesite’s NurseMagic™ as a promising AI solution for reducing nurse burnout and improving documentation efficiency, with strong potential in the rapidly growing post-acute care market, though profitability and long-term market share remain key challenges.
Amesite’s AI Tool Earns Nurse Nod, Eyes $800B Healthcare Market
DETROIT, MI – March 04, 2026 – In a significant nod from the nursing community, Amesite Inc.'s AI-powered platform, NurseMagic™, has been named a finalist for a “Best of Nursing Award” by Nurse.org, one of the largest online communities for nurses. The recognition in the AI Nursing Tool category comes less than two years after the product’s launch and signals growing acceptance for artificial intelligence in alleviating one of healthcare’s most persistent problems: administrative burnout.
For Amesite (NASDAQ: AMST), the nomination is more than a plaudit; it’s a crucial piece of external validation as the company executes an aggressive strategy to penetrate the U.S. post-acute care (PAC) market—a sector valued at over $500 billion in 2025 and projected by some analysts to surge past $800 billion by 2035.
The AI Co-Pilot for Overburdened Nurses
The central problem NurseMagic™ aims to solve is the overwhelming documentation burden placed on clinicians. In post-acute settings like home health, hospice, and skilled nursing facilities, nurses often spend hours on charting and administrative tasks. This “pajama time” charting, completed after a long shift, is not only a primary driver of burnout but also detracts from time that could be spent on direct patient care. These notes are critical for regulatory compliance and financial reimbursement, making their accuracy and completeness non-negotiable.
NurseMagic™ functions as an AI assistant, using structured prompts to help clinicians generate high-quality, compliant documentation far more efficiently. The platform’s initial success was built on a user-first strategy, launching first to individual nurses and caregivers. This allowed Amesite to refine its algorithms and workflows based on real-world usage across all 50 states. Users on app stores and nursing forums frequently praise the tool for saving them hours on documentation, improving the quality of their notes, and reducing work-related stress.
This grassroots adoption provided the company with a massive dataset and an engaged community, which proved invaluable in hardening the platform for enterprise-level deployment. The goal was to create a tool that nurses would actually want to use, a critical factor for successful technology adoption in any clinical setting.
A Strategic Surge into a Booming Market
The nomination from Nurse.org coincides with a period of explosive growth for Amesite, directly tied to its tiered product rollout. The company’s financial reports paint a clear picture of its strategic scaling. Following the launch of a “Teams+” tier in May 2025, Amesite reported a 2.4x quarter-over-quarter revenue increase. The subsequent launch of a census-based “Enterprise” tier in July 2025 fueled an 82% revenue jump in the next quarter, followed by another 69% quarterly increase.
By September 2025, a key milestone was reached: revenue from enterprise sales had surpassed sales to individual users. This pivot from a business-to-consumer (B2C) to a business-to-business (B2B) focus underscores the platform’s appeal to post-acute care operators seeking to standardize workflows, improve documentation defensibility, and reduce staff burnout across their organizations.
This strategic push is timed to capitalize on a market experiencing powerful tailwinds. The U.S. geriatric population is expanding rapidly, driving demand for post-hospitalization services. Concurrently, the healthcare industry's shift toward value-based care models puts a premium on efficiency and provable outcomes, making data-driven tools like NurseMagic™ increasingly essential. The software segment of this market alone is projected to grow at double-digit annual rates through the next decade.
“As we’ve shared with investors, NurseMagic™’s revenue growth has come in clear stages, aligned with the rollout of progressively higher-value product tiers,” said Dr. Ann Marie Sastry, CEO of Amesite, in a statement. “We went from assistant, to enterprise, to EMR based on what nurses and operators showed us they needed.”
The Power of Peer Validation and a Crowded Field
For any new technology in healthcare, trust is the most valuable currency. The nomination from Nurse.org, a platform that reaches millions of nurses monthly and recently acquired The Nursing Beat to become the largest online nursing community, provides a powerful dose of credibility. It suggests that NurseMagic™ is successfully solving a real problem for its target users.
“Serving nurses first is how we earned the right to serve post-acute,” noted Madison Bush, Director of Corporate Operations at NurseMagic™. “We started by listening at scale to nurses, caregivers, and non-clinical staff using NurseMagic™ on real shifts. That community told us where AI was genuinely valuable, and their input shaped our workflows, governance, and pricing.”
Amesite is not operating in a vacuum. The post-acute EMR and software space is dominated by established players like PointClickCare, WellSky, and Netsmart, many of whom have grown through acquisition. However, Amesite is attempting to differentiate itself not by replacing these systems outright, but by offering an “AI-native” solution. In December 2025, the company announced the NurseMagic™ EMR, designed to either coexist with legacy systems or replace them entirely.
By building from a foundation of a user-beloved AI assistant, Amesite believes it has an advantage in creating an EMR that addresses the deep-seated usability issues that plague many traditional systems. While the company has demonstrated impressive revenue growth from its new products, financial analysts note that overall profitability remains a future goal, with the company's stock showing the volatility typical of a high-growth tech firm. The challenge for Amesite will be to convert its user loyalty and targeted AI functionality into sustained market share and profitability against entrenched competitors.
As voting for the “Best of Nursing Awards” continues, the nomination itself serves as a significant milestone. It highlights the growing role of AI in the trenches of healthcare and validates Amesite's strategy of building technology for nurses, by listening to nurses, as it vies for a piece of a market measured in the hundreds of billions.
